> HDMA Testifies
      Supporting HR5839

> HDMA Applauds
      Introduction of
      HR 5839

> HDMA Applauds
      NCPA, FBI LEEDA and
      Purdue Pharma

> HDMA Commends
      California Board of
      Pharmacy Decision

> New Data Management
      & Sharing Research
      Now Available!


print page

 

 

 

Controlled Substance Ordering System (CSOS)

Description
HDMA has worked with the U.S. Drug Enforcement Administration (DEA) on an electronic commerce initiative to facilitate the electronic ordering of Schedule II Controlled Substances, commonly referred to as “CSOS.”

This important partnership involved dialogue and collaboration, as well as connecting the regulatory/business process necessities with the technical aspects of setting up an electronic ordering system for Schedule II controlled substances. HDMA and DEA began a series of discussions in 1999 that have evolved into the current initiative. The overall goal was to simplify the ordering of Schedule II controlled substances while retaining the underlying "closed distribution system" principles of the DEA Order Form (Form 222). This new process allows the automation of a number of other steps, such as verification, audits, and reporting.


General Information

Webinar


Committees/Task Forces


Contact
John Howells
Senior Director, Industry Relations
703-885-0277
jhowells@hdmanet.org

Anita Ducca
Senior Director, Regulatory Affairs & Healthcare Policy
703-885-0240
aducca@hdmanet.org

 
 
© Copyright Healthcare Distribution Management Association.
All rights reserved.
HDMA: M | C | D